Page last updated: 2024-08-24

fenproporex and sibutramine

fenproporex has been researched along with sibutramine in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boguszewski, CL; De Almeida, SM; Niclewicz, PA; Radominski, RB; Rodrigues, AM; Suplicy, Hde L	1
da Silva, CJ; dos Santos, JE; Satie Takahashi, C	1
Cohen, PA; Dal Molin, TR; De Carvalho, LM; Falcão, TM; Martini, M; Moreira, AP; Silva, CV; Zemolin, G	1
Boguszewski, CL; Cunha, DR; do Desterro de Figueiredo, M; dos Santos, CM; Radominski, R; Suplicy, H	1
Correr, CJ; Fernandez-Llimos, F; Lucchetta, RC; Otuki, MF; Pontarolo, R; Radominski, RB; Riveros, BS	1

Trials

2 trial(s) available for fenproporex and sibutramine

Article	Year
The cerebrospinal fluid/serum leptin ratio during pharmacological therapy for obesity. The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:4 Topics: Adolescent; Adult; Amphetamines; Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Humans; Lactones; Leptin; Middle Aged; Obesity; Orlistat; Weight Loss	2002
A comparative study of five centrally acting drugs on the pharmacological treatment of obesity. International journal of obesity (2005), 2014, Volume: 38, Issue:8 Topics: Adult; Amphetamines; Anti-Obesity Agents; Body Mass Index; Brazil; Cyclobutanes; Diet, Reducing; Diethylpropion; Female; Fluoxetine; Follow-Up Studies; Humans; Mazindol; Obesity; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Weight Loss	2014

Article

Year

The cerebrospinal fluid/serum leptin ratio during pharmacological therapy for obesity.

The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:4

Topics: Adolescent; Adult; Amphetamines; Anti-Obesity Agents; Appetite Depressants; Cyclobutanes; Humans; Lactones; Leptin; Middle Aged; Obesity; Orlistat; Weight Loss

2002

A comparative study of five centrally acting drugs on the pharmacological treatment of obesity.

International journal of obesity (2005), 2014, Volume: 38, Issue:8

Topics: Adult; Amphetamines; Anti-Obesity Agents; Body Mass Index; Brazil; Cyclobutanes; Diet, Reducing; Diethylpropion; Female; Fluoxetine; Follow-Up Studies; Humans; Mazindol; Obesity; Prospective Studies; Surveys and Questionnaires; Treatment Outcome; Weight Loss

2014

Other Studies

3 other study(ies) available for fenproporex and sibutramine

Article	Year
An evaluation of the genotoxic and cytotoxic effects of the anti-obesity drugs sibutramine and fenproporex. Human & experimental toxicology, 2010, Volume: 29, Issue:3 Topics: Amphetamines; Animals; Anti-Obesity Agents; Bone Marrow Cells; Comet Assay; Cyclobutanes; DNA Damage; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Leukocytes, Mononuclear; Male; Mice; Micronuclei, Chromosome-Defective; Risk Assessment	2010
A new approach to determining pharmacologic adulteration of herbal weight loss products. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2012, Volume: 29, Issue:11 Topics: Amphetamines; Anti-Anxiety Agents; Anti-Obesity Agents; Antidepressive Agents; Appetite Depressants; Brazil; Cyclobutanes; Dietary Supplements; Diuretics; Electric Conductivity; Electrophoresis, Capillary; Food Contamination; Food Inspection; Laxatives; Plant Preparations	2012
Diethylpropion and mazindol: An end to the discussion? Revista da Associacao Medica Brasileira (1992), 2017, Volume: 63, Issue:3 Topics: Amphetamines; Appetite Depressants; Brazil; Cyclobutanes; Diethylpropion; Drug Approval; Humans; Mazindol; Obesity; Risk Assessment; Treatment Outcome	2017